BST-1003

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameBST-1003
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiostratum Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiostratum Ab
Active IndicationsN/A
Inactive IndicationsNeoplasm Metastasis

Other Information

ATC CodeN/A
Related LinksN/A